Resultados de la búsqueda 411-420 of 1229 for ⌛팔로우주소 【위너보증.com / 가입코드 9122】 stake가입 ⌛

  1. Neurología - Ensayos clínicos

    ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...

  3. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  4. Oncología (médica) - Ensayos clínicos

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  5. Ensayos clínicos - Neurología

    Rochester, Minn. The purpose of this study is to follow patients with REM sleep behavior disorder (RBD) over time and learn which types of RBD patients may be ...

  6. Oncología radioterápica - Ensayos clínicos

    ... follow-up radiation therapy (but not surgery) and are in complete remission (no evidence of disease). This is an investigational study. Radiation therapy is ...

  7. Ensayos clínicos - Neurología

    Rochester, Minn. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  9. Ensayos clínicos - Neurología

    The purpose of this study is to investigate the effectiveness and safety of REC-2282 in patients with progressive NF2 mutated meningiomas who have either NF2 ...

  10. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...